Special Issue: “Drug Repurposing for Cancer Therapies”-Reference-Cited by-同舟云学术

Special Issue: “Drug Repurposing for Cancer Therapies”

Published:2024-01-16 Issue:2 Volume:25 Page:1092
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Xavier Cristina P. R.¹²^ORCID,Palmeira Andreia³⁴^ORCID

Affiliation:

1. i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal

2. Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal

3. LQOF—Laboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal

4. CIIMAR—Interdisciplinary Centre of Marine and Environmental Research, Terminal de Cruzeiros do Porto de Leixões, 4450-208 Matosinhos, Portugal

Abstract

Cancer is one of the primary global causes of death, thus addressing cancer therapy remains a significant challenge, especially in cases where cancers exhibit resistance to treatment [...]

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/25/2/1092/pdf

Reference12 articles.

1. The multi-factorial nature of clinical multidrug resistance in cancer;Assaraf;Drug Resist. Updates,2019

2. Weth, F.R., Hoggarth, G.B., Weth, A.F., Paterson, E., White, M.P.J., Tan, S.T., Peng, L., and Gray, C. (2023). Unlocking hidden potential: Advancements, approaches, and obstacles in repurposing drugs for cancer therapy. Br. J. Cancer.

3. Repurposing approved non-oncology drugs for cancer therapy: A comprehensive review of mechanisms, efficacy, and clinical prospects;Chawla;Eur. J. Med. Res.,2023

4. Repurposing some of the Well-Known Non-Steroid Anti-Inflammatory Drugs [Nsaids] for Cancer Treatment;Sousa;Curr. Top. Med. Chem.,2023

5. Rebelo, R., Polónia, B., Santos, L.L., Vasconcelos, M.H., and Xavier, C.P.R. (2021). Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals, 14.